Skip to Content
Merck
HomeWebinarsArtificial Intelligence-Based Screening and Selection of Co-Formers for Co-Crystallization

Artificial Intelligence-Based Screening and Selection of Co-Formers for Co-Crystallization



WEBINAR

70% of APIs under development are poorly water soluble which increases the risk of them failing during formulation. Co-crystallization is a rapidly growing technique used to tackle solubility challenges. However, it is challenging and resource intensive to find new co-crystals experimentally.

In recent years, several approaches have been developed to screen for co-crystals computationally. We developed mPredict™, a co-crystal prediction tool with quantum chemistry, statistical thermodynamics, and AI. It predicts co-crystal formation and, hence, optimal co-formers for your API. Besides being a strong improvement over physical modeling, it is also three times faster than random digital screening.

In this webinar, you will learn:

  • That co-crystallization is rapidly growing as a technique to tackle solubility challenges
  • About the challenges of co-crystallization and ways to overcome them
  • What are the key technical considerations to build an AI based co-former screening tool
  • About the advantages of using our cutting edge mPredict™ co-crystal prediction service

Speakers

Mitali Bhagwat

Mitali Bhagwat

Merck

Strategic Product Manager – Excipients Solid Application

Mitali is a strategic product manager in the field of excipients used for solid formulation drug development and is leading the group's digital strategy with its flagship product mPredict™. Mitali has a master's degree in pharmaceutical sciences and almost 10 years of work experience in the industry around product development and IP strategies. After completing her MBA in international management and working as a management consultant in the industry, her ambition now is to bring drug formulation closer to digital / AI technologies.

Rimson Muara Jaya

Rimson Muara Jaya

Merck

Customer Application Expert SEATWO

Rimson is a technical application expert, specializing in small to large molecules.  Rimson holds a pharmacist's degree and a master's in business administration. He has more than 10 years of extensive experience in the pharmaceutical industry, with a strong focus on project management, production, and GMP assurance for various small molecule pharmaceutical dosage forms.

Webinar Information

Pharma and biopharma manufacturing

  • Solid Formulation Strategies
  • Duration:1h

  • Language:English

  • Session 1:Tue, January 14, 2025 2:00 PM SGT

    Register Now


Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?